Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients

Table 2

Correlations of CEACAM1 protein expression with clinical and histological tumor parameters (missing values to : no information).

		Low CEACAM1 expression	High CEACAM1 expression
		<median	>median
Clinical stage	FIGO Ia–IIIb	4	14
	FIGO IIIc–IV	97	86	0.013
Grading	G1-2	29	26
	G3	75	74	0.762
Lymph node involvement	N0	21	28
	N1	67	57	0.185
Distant metastasis	M0	79	63
	M1	16	27	0.034
Residual tumor after surgery	No macroscopically visible tumor	67	71
	>1 cm	24	14
	>1 cm	13	11	0.273